Pioneering French oncologist Mathe dies at 88

October 18, 2010

(AP) -- Oncologist Georges Mathe, who in 1959 performed the world's first bone marrow transplant, has died, the French president's office said Monday. He was 88.

Nicolas Sarkozy's office said Mathe died on Friday, but did not provide any additional details.

"His contribution to the progress of remains major," the statement said. "In 1959, he performed the first bone marrow transplants on six Yugoslav physicians who had been accidentally irradiated at a nuclear power plant. Four of them survived."

Mathe was the first physician to use bone marrow transplantation to treat leukemia. The procedure involves giving patients a high dose of and radiation to kill cells. Transplanting bone marrow is also used to treat radiation and blood diseases including sickle cell anemia.

Mathe founded a specialized cancer center in the Paris suburb of Villejuif in the early 1960s and ran its blood disease unit until 1990, the statement said.

shares

Related Stories

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.